COVID-19: Mix and match vaccine study extended to include Moderna and Novavax jabs
A study assessing the benefits of mixing and matching coronavirus vaccines has been extended to include the Moderna and Novavax jabs. The Com-Cov study, led by the University of Oxford, has been investigating the immune responses of volunteers given a dose of the AstraZeneca vaccine followed by the Pfizer jab - and vice versa.
View the full story here: https://news.sky.com/story/covid-19-mix-and-match-vaccine-study-extended-to-include-moderna-and-novavax-jabs-12274349
